Q: The price has fallen to the $5 range and to about .5 of book value. Appears to be oversold. Time to buy?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Good morning 5i,
What are your thoughts on switching CF for HCG?
What are your thoughts on switching CF for HCG?
Q: An article in today's Globe highlighted that a few of the top analysts and execs seem to have done quite well for themselves in 2014, with their top investment banker making more money than just a couple of bank CEO's. Unfortunately for me, and I am sure many others, the stock price has not been as rewarding to me.
I understand that that industry can pay well and aside from my initial knee-jerk negative reaction, are these types of bonuses in-line with industry norms? Or is this a reflection on management paying themselves first and not giving a lot or thought about shareholders (which maybe is the industry norm)?
Thanks for the insight.
Paul F.
I understand that that industry can pay well and aside from my initial knee-jerk negative reaction, are these types of bonuses in-line with industry norms? Or is this a reflection on management paying themselves first and not giving a lot or thought about shareholders (which maybe is the industry norm)?
Thanks for the insight.
Paul F.
Q: I noticed big volume yesterday and a pop over $7.00 a share. I own CF at $12.00 a share. I know you prefer averaging up not down but woukd CF potentially be one to average down on considering the yield and management. I wish I had averaged down on BDI and ACQ since they have recovered nicely.
Q: I'm looking at Canaccord or Gluskin with a 3 to 5 year term in mind. Which one would you choose and why?
Thanks
Ron
Thanks
Ron
Q: The stock is down significantly and there is now an announcement of a major corporate shakeup. Was the reorg done in the natural course of business or a recognition that things are off the rails? Are the moves, in your opinion, and their stated strategy good for the company or a sign of confusion?
Thanks.
Paul F.
Thanks.
Paul F.
Q: Hi Peter & Ryan,
Based on your last answer about CF, would you recommend to increase position, eventhough it went down 45% since July 29th'14? Is it the right time or wait for the energy sector to settle down?
Merry Xmas,
Morris
Based on your last answer about CF, would you recommend to increase position, eventhough it went down 45% since July 29th'14? Is it the right time or wait for the energy sector to settle down?
Merry Xmas,
Morris
Q: Hi team, without regard to sector, but with the exception of oil and gas, I have some cash and would like to pick up 2 or 3 oversold stocks. Could you suggest 5 good quality good value stocks? Thanks so much.
Q: Would you buy CF today if you have a 2 year horizon?
Q: Was up a lot on cf now down a lot in this downturn. Earnings today looks like they missed estimates. Comments? Thanks.
Q: Hold CF and wondering with a long term view (5+years) would you recommend continue holding?
Q: Canaccord Genuity Group Inc continues to slide down with a further 8% loss today on relatively large volume. Any idea why?
Thanks
John
Thanks
John
Q: I have a general question as to how, and if, analysts' reviews affect stocks.
On Wednesday, TD Securities downgraded Canaccord Genuity Group to "hold" from "buy" with a price target of $12.50 (Canadian). The stock was around $11.00 at the time. It subsequently plummeted about 10% and continues to drop today.
Today, Raymond James upgraded Mullen Group to "market perform" from "underperform" but cut its price target to $25 (Canadian) from $27.50. The stock has dropped about 5% so far.
In both cases, the stocks were about 10% below the analysts target. Once was considered a downgrade, although it was still a hold. The other was considered an upgrade but its target was not going to yield any greater returns.
My question is threefold. Is "market perform" considered different than "hold" (since they seem pretty similar to me); secondly, why was one stock hammered so much and the other wasn't when they are both expected to perform about the same, at least as it pertains to their target prices; finally, should TD be considered impartial since they are downgrading a competitor.
I am hoping that with your insight, I will move closer to understanding how things work!
Thanks so much.
Paul F.
On Wednesday, TD Securities downgraded Canaccord Genuity Group to "hold" from "buy" with a price target of $12.50 (Canadian). The stock was around $11.00 at the time. It subsequently plummeted about 10% and continues to drop today.
Today, Raymond James upgraded Mullen Group to "market perform" from "underperform" but cut its price target to $25 (Canadian) from $27.50. The stock has dropped about 5% so far.
In both cases, the stocks were about 10% below the analysts target. Once was considered a downgrade, although it was still a hold. The other was considered an upgrade but its target was not going to yield any greater returns.
My question is threefold. Is "market perform" considered different than "hold" (since they seem pretty similar to me); secondly, why was one stock hammered so much and the other wasn't when they are both expected to perform about the same, at least as it pertains to their target prices; finally, should TD be considered impartial since they are downgrading a competitor.
I am hoping that with your insight, I will move closer to understanding how things work!
Thanks so much.
Paul F.
Q: Canaccord (CF) has dropped significantly in the past 2 days. Earnings release is upcoming on Nov 5th. Is there any negative news that would have a LT impact on their investment bank business or is this a good entry point? If not CF, are there alternatives you would recommend? Thanks for all the research you guys provide! Great learning experience. Thanks - John
Q: CF has fallen over 20% from it's one year high and shows continued weakness. What are your thoughts on the company going forward?
Q: Your thoughts on Canaccord's (CF) recent earnings please
Q: Canaccord traded in the $25 range in 2006 and 2007. Do you think it has the potential to reach this point once again given time? Also what were the circumstances of those past years that caused the stock to trade at that level? Thanks, J.
Q: Hi Peter. Please comment on Canaccord. Looks like significant fees to come regarding Amaya deal. Is this a good time to get in?
Many thanks for your great advice on Surge, Enghouse and Amaya. Great work!!
Cam
Many thanks for your great advice on Surge, Enghouse and Amaya. Great work!!
Cam
Q: Hi,
Unfortunately I did not buy CF after your report was released. Sure had a good run. Can you give us you opinion on the recent results released once you have had time to review and more importantly what kind of growth and future prospects you see for CF as a result? Thanks
Unfortunately I did not buy CF after your report was released. Sure had a good run. Can you give us you opinion on the recent results released once you have had time to review and more importantly what kind of growth and future prospects you see for CF as a result? Thanks
Q: CF.Agreed with your answers to Helen today.CF been on a tear since report of strong results on Feb 5($6.87) & your review on Jan 10($7.29).Thinking of buying tomorrow prior to release of results after market close on Jun 6.Worried that above already priced in expected result.Your normal good advice.Thanks a lot